• 1
    Schön M, Boehncke WH. Psoriasis – immunopathogenesis, genetics and therapeutic perspectives. N Engl J Med 2005; 352:1899912.
  • 2
    Rapp SR, Feldman SR, Exum ML et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41:4017.
  • 3
    Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352:168595.
  • 4
    Maradit-Kremers H, Nicola PJ, Crowson CS et al. Cardiovascular death in rheumatoid arthritis. Arthritis Rheum 2005; 52:72232.
  • 5
    McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med 1973; 288:912.
  • 6
    McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99:46975.
  • 7
    Boffetta P, Gridley G, Lindelof B. Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 2001; 117:15317.
  • 8
    Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19:22530.
  • 9
    Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988; 91:197201.
  • 10
    Gupta MA, Gupta AK, Watteel GN. Cigarette smoking in men may be a risk factor for increased severity of psoriasis of the extremities. Br J Dermatol 1996; 135:85960.
  • 11
    Binazzi M, Calandra P, Lisi P. Statistical association between psoriasis and diabetes: further results. Arch Dermatol Res 1975; 254:438.
  • 12
    Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986; 172:298304.
  • 13
    Seishima M, Seishima M, Mori S, Noma A. Serum lipid and apolipoprotein levels in patients with psoriasis. Br J Dermatol 1994; 130:73842.
  • 14
    Flohr T, Ohnesorge B. Heart rate adaptive optimization of spatial and temporal resolution for electrocardiogram-gated multislice spiral CT of the heart. J Comput Assist Tomogr 2001; 25:90723.
  • 15
    Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15:82732.
  • 16
    Arad Y, Goodman KJ, Roth M et al. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St Francis Heart Study. J Am Coll Cardiol 2005; 46:15865.
  • 17
    Arad Y, Spadaro LA, Roth M et al. Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St Francis Heart Study randomized clinical trial. J Am Coll Cardiol 2005; 46:16672.
  • 18
    Pohle K, Ropers D, Geitner P et al. Analysis of coronary calcifications versus Framingham and PROCAM risk assessment in patients with a first myocardial infarction. Int J Cardiol 2006; 110:2316.
  • 19
    Bhagat K, Vallance P. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96:30427.
  • 20
    Fukumoto Y, Shimokawa H, Ito A et al. Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs. J Cardiovasc Pharmacol 1997; 29:22231.
  • 21
    Leonardi CL, Powers JL, Metheson RT et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003; 349:201422.
  • 22
    Huo Y, Schober A, Forlow SB et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 2003; 9:617.
  • 23
    Ludwig RJ, Schultz JE, Boehncke WH et al. Activated, but not resting platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004; 122:8306.
  • 24
    Boehncke WH, Schön MP. Interfering with leukocyte rolling – a promising therapeutic approach in inflammatory skin disorders? Trends Pharmacol Sci 2003; 24:4952.
  • 25
    Marongiu F, Sorano GG, Bibbo C et al. Abnormalities of blood coagulation and fibrinolysis in psoriasis. Dermatology 1994; 189:327.
  • 26
    Vanizor KB, Orem A, Cimsit G et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003; 332:2330.
  • 27
    Schopf RE, Weber H, Morsches B. Enhanced procoagulant activity of mononuclear leukocytes in patients with atopic dermatitis and psoriasis. Arch Dermatol Res 1993; 285:3059.
  • 28
    Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res 2004; 114:3217.